EBMT NEWSLETTER | July 2014 | Volume 42 - Issue 3

EBMT
Important dates
Following the sad passing of Professor John Goldman, Founder and Editor of the journal since 1984, the journal has gone through somewhat of a restructure during the last few months.  Mohamad Mohty and Hillard Lazarus have stepped up to become Editors-in-Chief, with a team of 16 new Associate Editors being recruited and a new Editorial Board.  For the full listing click here.  
BMT publishes high quality, peer reviewed original research and reviews that address all aspects of the basic biology and clinical use of haemopoietic stem cell transplantation.
 
Average time to first decision = 10 days
 
Average time to online publication  = 24 days
 
 
Have you read these recent papers which have been highly cited by your peers?  
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
 Y Kanda
 
Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis
M A Gertz, M Q Lacy, A Dispenzieri, S K Kumar et al
 
HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis
M E Scheurer, J C Pritchett, E S Amirian, N R Zemke et al
 
Short-term sonic-hedgehog gene therapy to mitigate myelosuppression in highly irradiated monkeys: hype or reality?
M Drouet, P Garrigou, A Peinnequin & F Hérodin
 
Biologic markers of chronic GVHD
J Pidala, M Sarwal, S Roedder & S J Lee
 
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS  
S M Luger, O Ringdén, M-J Zhang, W S Pérez et al
 
Get your research the recognition it deserves - Submit to BMT TODAY
Bookmark and Share